TA125 Psoriatic arthritis (moderate to severe) - adalimumab: guidance (MS Word format)
The published full technology appraisal on Psoriatic arthritis (moderate to severe) - adalimumab including recommendations and methods used.
|
TA125 Psoriatic arthritis (moderate to severe) - adalimumab: guidance (MS Word format)
22 August 2007 (589 Kb 2 mins 51 sec) |
